Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-12

Clinical Trial Update: Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the use of naltrexone in combination with buprenorphine for adults with opioid use disorder transitioning from buprenorphine maintenan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)
  • Vivitrol (naltrexone extended-release injectable)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Opioid Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-02-12